NHS Logo

Neurofibromatosis type 1 : (Record no. 91369)

MARC details
000 -LEADER
fixed length control field 04784cam a2200613 i 4500
001 - CONTROL NUMBER
control field ocn857060612
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729131322.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130514s2013 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020676671
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
019 ## -
-- 1058234630
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781628081657
Qualifying information pdf
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1628081651
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1628081597
Qualifying information hbk.
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781628081596
Qualifying information hbk.
035 ## - SYSTEM CONTROL NUMBER
System control number 620125
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)857060612
Canceled/invalid control number (OCoLC)1058234630
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Neurofibromatosis type 1 :
Subtitle symptoms, treatment and prognosis
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical,
Date of production, publication, distribution, manufacture, or copyright notice [2013]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Genetics-Research and issues
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents NEUROFIBROMATOSIS TYPE 1 ; Library of Congress Cataloging-in-Publication Data; Contents ; Acknowledgment ; Introduction ; Chapter I Molecular Pathogenesis of Neurofibromatosis Type 1 ; Abstract ; Introduction ; Epidemiology of NF1 ; Clinical Features of NF1 ; Skin Manifestations ; Skeletal and Osseous Abnormalities ; Vascular Lesions ; Psychiatric Disorders and Cognitive Dysfunction; Rare Manifestations ; RASopathies ; Dysplasia and Developmental Defects ; Molecular Genetics of NF1 ; Genetic Diagnosis ; Tumors Associated with NF1 ; Disease Modifier Genes in NF1.
505 8# - CONTENTS
Contents Molecular Pathogenesis of NF1Using Systems Approaches to Study NF1 ; Current Treatment and Disease Management ; Conclusion ; References ; Chapter II Imaging of Plexiform Neurofibromas in Neurofibromatosis Type 1 ; Abstract ; Introduction ; Imaging Appearance of Plexiform Neurofibromas ; Plexiform Neurofibroma Types ; Volumetric Analysis ; Cranial Nerves ; Spinal Nerves ; Neck, Mediastinum, Chest ; Abdomen, Pelvis ; Malignant Peripheral Nerve Sheath Tumors (MPNSTs) ; Conclusion ; References ; Chapter III Surgical Treatment of GiantNeurofibromas ; Abstract ; Introduction.
505 8# - CONTENTS
Contents Surgical Techniques Discussion ; Conclusion ; References ; Chapter IV Neurofibromatosis Type 1-Associated Nervous System Tumors and Current Treatment Strategies ; Abstract ; Introduction ; Central Nervous System Tumors in Children with NF1 ; Low Grade Glioma: Clinical Presentation ; Low Grade Glioma: Imaging Characteristics ; Low Grade Glioma: Prognosis ; Low Grade Glioma: Treatment Modalities ; 1. Role of Surgery ; 2. Radiation Therapy ; 3. Chemotherapy; 4. Targeted Therapy ; RAS-MAPK Pathway; Peripheral Nervous System Tumors in Children with NF1.
505 8# - CONTENTS
Contents Plexiform Neurofibromas: Clinical Presentation Plexiform Neurofibromas: Imaging Characteristics ; Plexiform Neurofibromas: Prognosis ; Plexiform Neurofibromas: Treatment Modalities ; 1. Role of Surgery ; 2. Radiation Therapy ; 3. Chemotherapy ; 4. Targeted Therapy ; a) mTOR Pathway ; Interferon Treatment ; b) Anti-angiogenic Treatment ; c) Tyrosine Kinase Inhibitor Treatment ; Malignant Peripheral Nerve Sheath Tumor (MPNST): Clinical Presentation ; MPNST: Imaging Characteristics ; MPNST: Prognosis ; MPNST: Treatment Modalities ; 1. Role of Surgery ; 2. Radiation Therapy ; 3. Chemotherapy.
505 8# - CONTENTS
Contents 4. Targeted Therapy a) Tyrosine Kinase Inhibitor Treatment; b) Angiogenic Pathways ; c) Cytoskeletal Remodeling ; Conclusion ; References ; Chapter V Outcome Measures for Optic Pathway Gliomas ; Abstract ; Introduction ; Epidemiology of OPGs ; Presentation of OPGs ; Clinical Symptoms ; Diagnostic Imaging ; Pathology ; Management of OPGs ; Clinical Course ; Surveillance ; Treatment ; Outcome Measures ; Anatomical Outcomes (MRI) ; Visual Outcomes ; Alternative Outcome Measures ; Diffusion and Perfusion Imaging; Diffusion Tensor Imaging ; Positron Emission Tomography.
590 ## - LOCAL NOTE (RLIN)
Local note WorldCat record variable field(s) change: 050
650 #0 - SUBJECT HEADINGS
Subject term Neurofibromatosis.
9 (RLIN) 7119
650 #0 - SUBJECT HEADINGS
Subject term Neurofibromatosis in children.
700 1# - ADDED PERSONAL NAME
Added personal author Karajannis, Matthias A.,
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Allen, Jeffrey,
Relator term editor.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Genetics--research and issues series.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 10737397
938 ## -
-- EBSCOhost
-- EBSC
-- 620125
938 ## -
-- ebrary
-- EBRY
-- ebr10740747
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3022879
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=620125 28/11/2022 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions